-
Maternal cardiac adaptation and fetal growth.
Ling HZ, Guy GP, Bisquera A, Nicolaides KH, Kametas NA.
Am J Obstet Gynecol 2020;18:S0002-9378(20)32575-8. pdf -
Impact of biometric measurement error on identification of small- and large-for-gestational-age fetuses.
Wright D, Wright A, Smith E, Nicolaides KH.
Ultrasound Obstet Gynecol 2020;55:170-176. pdf -
Fetal Medicine Foundation fetal and neonatal population weight charts.
Nicolaides KH, Wright D, Syngelaki A, Wright A, Akolekar R.
Ultrasound Obstet Gynecol 2018;52:44-51. pdf -
ISUOG Practice Guidelines: role of ultrasound in twin pregnancy.
Khalil A, Rodgers M, Baschat A, Bhide A, Gratacos E, Hecher K, Kilby MD, Lewi L, Nicolaides KH, Oepkes D, Raine-Fenning N, Reed K, Salomon LJ, Sotiriadis A, Thilaganathan B, Ville Y.
Ultrasound Obstet Gynecol 2016;47:247-63. pdf -
Inverted Pyramid of Care.
Sonek JD, Kagan KO, Nicolaides KH.
Clin Lab Med 2016;36:305-17. pdf -
Maternal age and adverse pregnancy outcomes: a cohort study.
Khalil A, Syngelaki A, Maiz N, Zinevich Y, Nicolaides KH.
Ultrasound Obstet Gynecol 2013;42:634-43. pdf -
Maternal serum retinol-binding protein-4 at 11-13weeks' gestation in normal and pathological pregnancies.
Nanda S, Nikoletakis G, Markova D, Poon LC, Nicolaides KH.
Metabolism 2013;62:814-9. -
Maternal serum resistin at 11 to 13 weeks' gestation in normal and pathological pregnancies.
Nanda S, Poon LC, Muhaisen M, Acosta IC, Nicolaides KH.
Metabolism 2012;61:699-705. -
A model for a new pyramid of prenatal care based on the 11 to 13 weeks' assessment.
Nicolaides KH.
Prenat Diagn 2011;31:3-6. -
Turning the pyramid of prenatal care.
Nicolaides KH.
Fetal Diagn Ther 2011;29:183-96. -
Fetal RHD genotype detection from circulating cell-free fetal DNA in maternal plasma in non-sensitized RhD negative women.
Bombard AT, Akolekar R, Farkas DH, Vanagtmael AL, Aquino F, Oeth P, Nicolaides KH.
Prenat Diagn 2011;31:802-8. -
Fetal RHD Genotyping in Maternal Plasma at 11-13 Weeks of Gestation.
Akolekar R, Finning K, Kuppusamy R, Daniels G, Nicolaides KH.
Fetal Diagn Ther 2011;29:301-6. -
Prediction of severe fetal anemia in red blood cell alloimmunization after previous intrauterine transfusions.
Scheier M, Hernandez-Andrade E, Fonseca EB, Nicolaides KH.
Am J Obstet Gynecol 2006;195:1550-6. -
Prediction of fetal anemia in rhesus disease by measurement of fetal middle cerebral artery peak systolic velocity.
Scheier M, Hernandez-Andrade E, Carmo A, Dezerega V, Nicolaides KH.
Ultrasound Obstet Gynecol 2004;23:432-6. -
Predicting the severity of fetal anemia using time-domain measurement of volume flow in the fetal aorta.
Harrington K, Fayyad A, Nicolaides KH.
Ultrasound Obstet Gynecol 2004;23:437-41. -
Severe hemolytic disease of the fetus following in vitro fertilization with anonymously donated oocytes.
Patel RK, Nicolaides K, Mijovic A.
Transfusion 2003;43:119-20. -
Fetal bone metabolism in normal and rhesus isoimmunised pregnancies.
Ogueh O, Wright EM, Jones J, Alaghband-Zadeh J, Nicolaides KH, Johnson MR.
BJOG 2001;108:986-92. -
Early ultrasound diagnosis and follow-up of molar pregnancies.
Jauniaux E, Nicolaides KH.
Ultrasound Obstet Gynecol 1997;9:17-21. -
Perinatal features associated with placental mesenchymal dysplasia.
Jauniaux E, Nicolaides KH, Hustin J.
Placenta 1997;18:701-6. -
Fetal venous, arterial, and intracardiac blood flows in red blood cell isoimmunization.
Hecher K, Snijders R, Campbell S, Nicolaides KH.
Obstet Gynecol 1995;85:122-8.